Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Class of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
99
100
Next >
AirAllergen Reinforces Commitment to Customer Service and Education in Indoor Air Quality
February 20, 2025
Via
Press Advantage
Topics
Product Recall
Exposures
Legal
Product Safety
iQure Pharma, Zefit’s Partner, Secures FDA Orphan Drug Designation for Dravet Syndrome Treatment
February 20, 2025
Via
AB Newswire
Exposures
Product Safety
International Process Solutions Offers Onsite Temperature Calibration Services
February 20, 2025
Via
AB Newswire
Exposures
Product Safety
ImmunityBio Surges On FDA Green Light For Expanded Bladder Cancer Vaccine Access — Retail Buzz Intensifies
February 20, 2025
Via
Stocktwits
Tickers
IBRX
MRK
Exposures
Product Safety
Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder
February 19, 2025
Via
Benzinga
Tickers
HRMY
Exposures
Product Safety
Roger B. Bagwell, Ph.D., is named the Actuated Medical Director, Neural Device Operations
February 20, 2025
Via
PRLog
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Medcrypt Unveils Enhanced Helm SBOM Vulnerability Management Tool: The First Industry-Specific Solution for Medical Device Manufacturers
February 19, 2025
Via
PRUnderground
Exposures
Product Safety
Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
February 19, 2025
Via
MarketBeat
Tickers
SLDB
SRPT
Exposures
Product Safety
Moderna: A Generational Opportunity for Investors in 2025
February 19, 2025
Via
MarketBeat
Tickers
MRNA
Exposures
COVID-19
Product Safety
DOGE Reportedly Fires FDA Staff Reviewing Elon Musk's Neuralink: 'We Should Be Worried About The Whole Trial,' Says Former Official
February 19, 2025
Via
Benzinga
Tickers
TSLA
Exposures
Product Safety
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at 6th Glioblastoma Drug Development Summit
February 18, 2025
Via
Investor Brand Network
Tickers
CNSP
Exposures
Product Safety
Axsome's AXS-05 In Alzheimer's Agitation Could Be Billion Dollar Opportunity, Says Analyst
February 18, 2025
Via
Benzinga
Tickers
AXSM
ITCI
JNJ
Exposures
Product Safety
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Files Provisional Patent for SPC-15 Dual-Action Treatment
February 18, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Tickers
SILO
Exposures
Intellectual Property
Product Safety
Final APLT Deadline Reminder: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
February 18, 2025
Via
NewMediaWire
Topics
Lawsuit
Tickers
APLT
Exposures
Financial
Legal
Product Safety
Final APLT Deadline Reminder: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
February 18, 2025
Via
TheNewswire.com
Topics
Lawsuit
Tickers
APLT
Exposures
Financial
Legal
Product Safety
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week
February 18, 2025
Via
Benzinga
Tickers
GSK
Exposures
Product Safety
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
February 18, 2025
Via
Benzinga
Tickers
LLY
NVO
SNY
Exposures
Product Safety
APLT Deadline in 1 Day: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
February 17, 2025
Via
NewMediaWire
Topics
Lawsuit
Tickers
APLT
Exposures
Financial
Legal
Product Safety
APLT Deadline in 1 Day: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
February 17, 2025
Via
TheNewswire.com
Topics
Lawsuit
Tickers
APLT
Exposures
Financial
Legal
Product Safety
DEADLINE TOMORROW: Kaplan Fox Reminds Investors of a Deadline for a Securities Class Action Lawsuit Against Applied Therapeutics (APLT)
February 17, 2025
Via
NewMediaWire
Topics
Lawsuit
Tickers
APLT
Exposures
Financial
Legal
Product Safety
DEADLINE TOMORROW: Kaplan Fox Reminds Investors of a Deadline for a Securities Class Action Lawsuit Against Applied Therapeutics (APLT)
February 17, 2025
Via
TheNewswire.com
Topics
Lawsuit
Tickers
APLT
Exposures
Financial
Legal
Product Safety
Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
February 15, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
APLT
Exposures
Financial
Legal
Product Safety
Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
February 15, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
APLT
Exposures
Financial
Legal
Product Safety
AstraZeneca's Imfinzi Perioperative Regimen Shows Improved Survival Outcomes In Bladder Cancer Patients
February 14, 2025
Via
Benzinga
Tickers
AZN
Exposures
Product Safety
Small-Cap OS Therapies Inks Commercial Manufacture Agreements For Lead Cancer Drug For Rare Type Of Bone Cancer
February 14, 2025
Via
Benzinga
Tickers
OSTX
Exposures
Product Safety
ISO-CERT International Certification Office Expands Services for ISO, FDA, and CE Marking
February 14, 2025
Via
Get News
Exposures
Product Safety
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
February 14, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
APLT
Exposures
Financial
Legal
Product Safety
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
February 14, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
APLT
Exposures
Financial
Legal
Product Safety
Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing
February 14, 2025
Via
The Motley Fool
Tickers
VRTX
Exposures
Product Safety
Bob's Repair AC, Heating and Solar Experts Las Vegas Launches Workforce and Innovation Initiative to Tackle HVAC Changes
February 13, 2025
Via
GetFeatured
Topics
Product Recall
Exposures
Legal
Product Safety
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.